In this episode of Blueprints for Better Benefits, we shine a light on one of the most misunderstood, and most expensive, drivers of employer healthcare costs: pharmacy rebates.
Rebates are often marketed as savings. In reality, they frequently inflate drug prices, obscure true costs, and quietly divert dollars away from employers and employees. What looks good on paper rarely shows up in lower premiums or reduced out-of-pocket costs.
We break down how Pharmacy Benefit Managers (PBMs) negotiate rebates with drug manufacturers, why those dollars often disappear into opaque contracts, and how this system rewards higher-priced drugs instead of lower-cost alternatives. The result? Employers pay more every year while believing rebates are working in their favor.
This episode is about understanding incentives—and why they’re not aligned with employers.
What We Cover
The Pharmacy Rebate Illusion
Rebates don’t work like consumer discounts. Unlike a rebate at retail that lowers your price at checkout, PBM rebates are collected behind the scenes, often retained by PBMs or carriers and excluded from premium calculations. Higher drug prices frequently mean larger rebates, which creates incentives to keep expensive drugs on formularies.
Vertical Integration: Follow the Money
We explain how major carriers have vertically integrated insurance, PBMs, specialty pharmacies, and provider services. By “paying themselves” through owned entities, carriers comply with ACA Medical Loss Ratio rules while capturing revenue at multiple layers, often at the employer’s expense.
Why Premiums Don’t Go Down
Pharmacy rebates don’t count toward MLR. That means premiums can rise even when rebate revenue grows. Employers are left with higher costs and limited visibility into where their dollars actually go.
Case Study: Humira vs. Biosimilars
We walk through why Humira’s price increased even after biosimilars entered the market—and why dramatically cheaper options like Yusimry are often excluded from formularies. The answer isn’t clinical. It’s financial.
The PBM Money Flow—Simplified
Employer → Health Plan → PBM → Pharmacy → Wholesaler → Manufacturer.
At every step, hidden currents, rebates, admin fees, specialty pharmacy markups—add cost without adding value.
Why This Matters
Pharmacy spend is one of the fastest-growing components of healthcare cost. Without transparency:
- Employers overpay
- Employees face higher deductibles
- Cheaper drugs stay out of reach
- Costs compound year after year
Understanding rebates isn’t optional anymore, it’s foundational.
Who This Episode Is For
✔ Employers with 50–750 employees
✔ CFOs and HR leaders
✔ Benefits decision-makers
✔ Organizations exploring self-funding
✔ Anyone tired of paying more without answers
Want Transparency Instead of Guesswork?
We are Triforta.
📩 hello@triforta.com
🌐 https://www.triforta.com/education
🔗 LinkedIn @Triforta-partners
Press play. This is where pharmacy strategy gets real.